The Scientist

» breast cancer

Most Recent

image: Stem Cell Alter Egos

Stem Cell Alter Egos

By | April 1, 2014

Researchers show that cancer stem cells can exist in two distinct and interconvertible states.

1 Comment

image: Bodybuilders Take Breast Cancer Drug

Bodybuilders Take Breast Cancer Drug

By | February 17, 2014

Tamoxifen, an endocrine therapy for women with breast cancer, is found in a supplement marketed to bodybuilders.

0 Comments

image: Top 10 Innovations 2013

Top 10 Innovations 2013

By | December 1, 2013

The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.

1 Comment

image: Decoding Breast Cancer Drug Resistance

Decoding Breast Cancer Drug Resistance

By | November 3, 2013

Common mutations in metastasized breast tumors suggest how the cancer can develop resistance to frontline drugs.

2 Comments

image: NFL Gear Yields Little for Cancer

NFL Gear Yields Little for Cancer

By | October 16, 2013

Only a small proportion of money made from breast cancer-themed football merchandise actually supports efforts to combat the disease.  

0 Comments

image: Contributors

Contributors

By | April 1, 2013

Meet some of the people featured in the April 2013 issue of The Scientist.

0 Comments

image: Cancer Gene Bonanza

Cancer Gene Bonanza

By | March 27, 2013

International collaboration doubles the number of genetic regions associated with breast, prostate, and ovarian cancers.

2 Comments

image: Cancer Research Advocate Dies

Cancer Research Advocate Dies

By | March 5, 2013

A champion of breast cancer awareness in the African-American community passes away at 63.

0 Comments

image: Little Cancer Risk from Fukushima

Little Cancer Risk from Fukushima

By | March 1, 2013

A new report from the World Health Organization predicts only very minimal increases in cancer risk for residents in the vicinity of the nuclear disaster.

0 Comments

image: Antibody-Drug Combo Approved

Antibody-Drug Combo Approved

By | February 25, 2013

The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech